These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14679871)

  • 1. Treating dyspepsia: new OTC drug changes the economic picture.
    Dis Manag Advis; 2003 Oct; 9(10):133-4, 129. PubMed ID: 14679871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPIs for upper digestive symptoms: EBM does not support empirical practice.
    Dumitrascu DL
    Rom J Gastroenterol; 2005 Jun; 14(2):203-4; author reply 204-5. PubMed ID: 15990943
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyspepsia and GERD: breaking the rules.
    Vakil N
    Am J Gastroenterol; 2005 Jul; 100(7):1489-90. PubMed ID: 15984969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of dyspepsia.
    Talley NJ; Vakil N;
    Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
    Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
    Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptic ulcer disease.
    Louw JA
    Curr Opin Gastroenterol; 2006 Nov; 22(6):607-11. PubMed ID: 17053437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA; Shaheen NJ; Schommer JC
    Clin Ther; 2005 Sep; 27(9):1478-87. PubMed ID: 16291421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-ulcer dyspepsia syndrome].
    Maev IV
    Eksp Klin Gastroenterol; 2002; (2):37-42. PubMed ID: 12046385
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial.
    Krol N; Wensing M; Haaijer-Ruskamp F; Muris JW; Numans ME; Schattenberg G; Balen J; Grol R
    Aliment Pharmacol Ther; 2004 Apr; 19(8):917-22. PubMed ID: 15080853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPI [corrected].
    Leontiadis GI; Howden CW
    Am J Gastroenterol; 2006 Sep; 101(9):2000-2. PubMed ID: 16968505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
    Meineche-Schmidt V
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
    Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.